Neuracle Lifesciences Pvt. Ltd., a leading Neuropsychiatry PCD Franchise in India, specializes in mental health solutions for schizophrenia, depression, bipolar, OCD, anxiety, and more with 300+ WHO-GMP, DCGI-approved products like anti-depressants, anti-psychotics, anxiolytics. Eco-friendly manufacturing, advanced R&D, strict quality. Market growth: USD 7.25B (2024) to 23.75B (2035). Franchise benefits: monopoly rights, incentives, promo materials, 20-50% margins, Pan-India support. Visit: https://www.neuraclelife.com/